Company Info

Number of Employees

3580

Visit Website

PCI Pharma Services

CDMO, Packaging, Supply Chain Logistics

Tagline

Excellence In Pharmaceutical Outsourcing

Overview

The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches each year and over five decades in the healthcare services business. Leading technology and continued investment enable us to address global development needs throughout the product life cycle — from phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pci.com

Company Services

Services/CapabilitiesCDMO

+ Development Services

Analytical Development & Validation
Preformulation/Formulation
Release & QA/QC Testing
Stability Testing

+ Drug Product Manufacturing

Clinical Trial Material Manufacturing
Controlled Substance Drug Products
Cytotoxic / High Potency Compounds (OEL < 1µg/m3)
Encapsulation/Capsules Manufacturing (Hard, Soft)
Liquid/Semi-Solid Dosage Manufacturing (Non Sterile liquid, creams, ointments)
Solid Dosage Manufacturing (Tablet, Powder)

+ Packaging

Blisters
Bottles
Carton Packaging
Clinical Trials Packaging
Creams/Ointments/Gels Packaging
High Speed Lines
Labeling
Non Sterile Liquid Packaging
Serialization / Aggregation
Storage/Warehousing
Strip (Alu/Alu, PVC, PVDC)

Company Info

PCI Pharma Services

Tagline

Overview

Company Services

Services/CapabilitiesCDMO

Focus Area/Product TypeCDMO

Services/CapabilitiesSupply Chain Logistics

Contributions

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients

Q: What’s the key to being a leader in the industry?

Q: What important company milestone do you anticipate reaching in 2022?

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

An Evolving Biologics Landscape and Driving Innovation and Opportunity

Delivering the Full Value Chain for Oncology Clinical Trials

Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients